Company intelligence / Profile preview

Labiotech

Berlin, Berlin, Germany

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Labiotech is a leading digital media platform dedicated to the European biotechnology industry. Founded in 2014 and headquartered in Berlin, the company provides comprehensive coverage of the life sciences sector through news articles, deep-dive reports, and the 'Beyond Biotech' podcast. It serves as a vital information hub for biotech professionals, investors, and researchers, tracking clinical developments, corporate deals, and technological innovations. In January 2022, Labiotech was acquired by Inpart (formerly Inova) to bolster its suite of life science information and partnering solutions.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

BIO-EuropeEBD Group

Beyond the preview

Go deeper on Labiotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Labiotech.

Explore the full profile